Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 63, Issue 3, 2016, Pages 756-763

  Lee, Jung Hee ^a   Ko, Young Guk ^a,b   Shin, Dong Ho ^a,b   Kim, Jung Sun ^a,b   Kim, Byeong Keuk ^a,b   Choi, Donghoon ^a,b   Hong, Myeong Ki ^a,b   Jang, Yangsoo ^a,b  

^a Yonsei University Health System   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; COMPLICATION; DISEASE FREE SURVIVAL; DYSLIPIDEMIAS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, LDL; DISEASE-FREE SURVIVAL; DYSLIPIDEMIAS; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959555315     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2015.09.059     Document Type: Article

References (26)

1. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, J.W. Olin, and et al. Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
2. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, T.J. McCann, and et al. Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
3. G.A. Antoniou, R.K. Fisher, G.S. Georgiadis, S.A. Antoniou, and F. Torella Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis Vascul Pharmacol 63 2014 79 87
4. P.G. Steg, D.L. Bhatt, P.W. Wilson, R. D'Agostino Sr., E.M. Ohman, J. Rother, and et al. One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 2007 1197 1206
5. Z.J. Zheng, A.R. Sharrett, L.E. Chambless, W.D. Rosamond, F.J. Nieto, D.S. Sheps, and et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study Atherosclerosis 131 1997 115 125
6. G.M. Welten, O. Schouten, S.E. Hoeks, M. Chonchol, R. Vidakovic, R.T. van Domburg, and et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease J Am Coll Cardiol 51 2008 1588 1596
7. D. Pereg, A. Elis, Y. Neuman, M. Mosseri, D. Segev, M. Granek-Catarivas, and et al. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention Coron Artery Dis 25 2014 79 82
8. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin, and et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 654
9. P.R. Moreno, and V. Fuster The year in atherothrombosis J Am Coll Cardiol 44 2004 2099 2110
10. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
11. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, and et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
12. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, and et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
13. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 S1 S45
14. A.D. Sniderman, D. Blank, R. Zakarian, J. Bergeron, and J. Frohlich Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula Clin Biochem 36 2003 499 504
15. K.B. Won, H.J. Chang, S.J. Hong, Y.G. Ko, M.K. Hong, Y. Jang, and et al. Prognostic usefulness of metabolic syndrome compared with diabetes in Korean patients with critical lower limb ischemia treated with percutaneous transluminal angioplasty Yonsei Med J 55 2014 46 52
16. S.J. Hong, Y.G. Ko, Y. Suh, D.H. Shin, J.S. Kim, B.K. Kim, and et al. Outcomes of stents covering the deep femoral artery origin EuroIntervention 10 2014 632 639
17. S.J. Hong, Y.G. Ko, J.S. Kim, M.K. Hong, Y. Jang, and D. Choi Midterm outcomes of subintimal angioplasty supported by primary proximal stenting for chronic total occlusion of the superficial femoral artery J Endovasc Ther 20 2013 782 791
18. S.J. Hong, Y.G. Ko, D.H. Shin, J.S. Kim, B.K. Kim, D. Choi, and et al. Outcomes of spot stenting versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery JACC Cardiovasc Interv 8 2015 472 480
19. S. Kim, D. Choi, S. Shin, D.H. Shin, J.S. Kim, B.K. Kim, and et al. Dorsal-plantar loop technique using chronic total occlusion devices via anterior tibial artery Yonsei Med J 54 2013 534 537
20. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White, and et al. Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
21. European Association for Cardiovascular Prevention and Rehabilitation Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, and et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
22. D. Pereg, Y. Neuman, A. Elis, S. Minha, M. Mosseri, D. Segev, and et al. Comparison of lipid control in patients with coronary versus peripheral artery disease following the first vascular intervention Am J Cardiol 110 2012 1266 1269
23. C.P. Cannon, M.A. Blazing, R.P. Giugliano, A. McCagg, J.A. White, P. Theroux, and et al. Ezetimibe added to statin therapy after acute coronary syndromes N Engl J Med 372 2015 2387 2397
24. J.G. Robinson, M. Farnier, M. Krempf, J. Bergeron, G. Luc, M. Averna, and et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events N Engl J Med 372 2015 1489 1499
25. Cholesterol Treatment Trialists Collaboration C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, N. Bhala, and et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
26. K.H. Cho, M.H. Jeong, K.W. Park, H.S. Kim, S.R. Lee, J.K. Chae, and et al. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥50% reduction from baseline versus <70 mg/dL Int J Cardiol 187 2015 478 485